QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
- Conditions
- Acute Kidney Injury Due to SepsisAcute Kidney Injury
- Interventions
- Device: QUELIMMUNE (SCD-PED)
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- SeaStar Medical
- Target Recruit Count
- 300
- Registration Number
- NCT06517810
- Locations
- 🇺🇸
Children's of Alabama, Birmingham, Alabama, United States
🇺🇸Lucile Packard Children's Hospital Stanford, Palo Alto, California, United States
🇺🇸UCSF Benioff Children's, San Francisco, California, United States
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - a Randomized Clinical Trial in Acute Kidney Injury
- Conditions
- Acute Kidney Injury
- Interventions
- Other: Standard of CareDevice: Selective Cytopheretic Device
- First Posted Date
- 2023-03-07
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- SeaStar Medical
- Target Recruit Count
- 200
- Registration Number
- NCT05758077
- Locations
- 🇺🇸
University of Alabama Birmingham Hospital, Birmingham, Alabama, United States
🇺🇸Central Arkansas Veterans Healthcare, Little Rock, Arkansas, United States
🇺🇸Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19
- Conditions
- Continuous Renal Replacement TherapyCOVID-19Pulmonary Edema
- Interventions
- Device: C2RxOther: Standard of Care (SOC)
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2020-12-14
- Lead Sponsor
- SeaStar Medical
- Registration Number
- NCT04537975
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
- Conditions
- ARDSCOVIDAKI
- Interventions
- Device: SCD
- First Posted Date
- 2020-05-20
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- SeaStar Medical
- Target Recruit Count
- 22
- Registration Number
- NCT04395911
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Henry Ford Health System, Detroit, Michigan, United States
🇺🇸University of Kentucky, Lexington, Kentucky, United States
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
- Conditions
- Acute on Chronic Systolic Congestive Heart FailureCardiorenal Syndrome
- Interventions
- Device: Selective Cytopheretic Device
- First Posted Date
- 2019-02-11
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- SeaStar Medical
- Target Recruit Count
- 20
- Registration Number
- NCT03836482
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
- Conditions
- Acute Kidney Injury
- Interventions
- Device: SCD
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2021-04-27
- Lead Sponsor
- SeaStar Medical
- Target Recruit Count
- 134
- Registration Number
- NCT01400893
- Locations
- 🇺🇸
Dallas VA Medical Center, Dallas, Texas, United States
🇺🇸Erlanger Hospital, Chattanooga, Tennessee, United States
🇺🇸Baystate Medical Center, Springfield, Massachusetts, United States
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
- Conditions
- Acute Renal Failure
- Interventions
- Device: Selective cytopheretic device (SCD)
- First Posted Date
- 2010-02-22
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- SeaStar Medical
- Target Recruit Count
- 35
- Registration Number
- NCT01072682
- Locations
- 🇺🇸
University of Alabama Birmingham, Birmingham, Alabama, United States
🇺🇸Denver Nephrology, Denver, Colorado, United States
🇺🇸George Washington University, Washington, District of Columbia, United States